4075-13-2 (3-氯二环[3.2.1]辛基-2-烯(内型和外型异构体混合物),(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one)

(17alpha)-17-羟基雄甾-4-烯-3-酮;3-氯二环[3.2.1]辛基-2-烯(内型和外型异构体混合物);

(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;19-Aldotestosterone;(17α)-17-Hydroxyandrost-4-en-3-one;(17β)-17-Hydroxy-3-oxoandrost-4-en-19-al;androst-4-en-19-al, 17-hydroxy-3-oxo-, (17β)-;LogP;19-Oxotestosterone;19-aldehyde-testosterone;(17beta)-17-hydroxy-3-oxoandrost-4-en-19-al;4075-13-2;19-OXO-TESTOSTERONE;C05295;Q27105040;CHEBI:75308;(8S,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde;DTXSID501020616;SCHEMBL1332182;

TXNCGXATKOMEQC-KOUJMVCDSA-N

1S/C19H26O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10-11,14-17,22H,2-9H2,1H3/t14-,15-,16-,17-,18-,19+/m0/s1

O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@]4(C=O)[C@H]3CC[C@@]21C)=O